On the synthesis, isolation, and radiochemical studies for the preparationof in-house kits for Tc-99m-meso- and d,l-HMPAO: A few additional observations
S. Banerjee et al., On the synthesis, isolation, and radiochemical studies for the preparationof in-house kits for Tc-99m-meso- and d,l-HMPAO: A few additional observations, NUCL MED BI, 26(3), 1999, pp. 327-338
The simple procedure documented for the synthesis of d,l-hexamethyl propyle
ne amineoxime (d,l-HMPAO), the widely used radiopharmaceutical precursor fo
r cerebral perfusion studies, has provided no clue to the inherent difficul
ties associated with the isolation of this desired isomer in moderate yield
s from the diastereomeric mixture. In addition, determination of the diaste
reomeric purity of the isolated fractions with the help of suitable analyti
cal techniques has posed a major challenge. Herein, we report the protocol
standardized for the purification and isolation of d,l-HMPAO in significant
ly improved yields from the crude diastereomeric mixture by fractional crys
tallization using a dual solvent system. In addition to the use of high res
olution H-1-NMR, C-13-NMR as a suitable analytical tool for conclusive dete
rmination of the diastereomeric composition of HMPAO is being reported for
the first time. Intermediate stages of crystallisation in the process of pu
rification yielded a third product resulting in reduction of the yield of t
he desired product. Attempts made to characterize this product are discusse
d. Labelling of d,l-HMPAO with Tc-99m was standardized in our laboratory us
ing stannous tartrate as the reducing agent The radiochemical studies of th
e meso isomer, which is also isolated in the process of crystallization in
adequate amounts, have been standardized with a view to investigating its p
otential use for leukocyte labelling studies. The biodistribution studies o
f the Tc-99m complexes prepared from the pure meso and d,l isomer in Swiss
mice are reported. Diastereomeric forms of HMPAO were isolated in increased
yields using an improved protocol by fractional crystallization involving
a dual solvent system. High resolution C-13-NMR spectroscopy has been utili
zed to provide a conclusive analytical tool for efficient and simple screen
ing of the diastereomeric composition. An additional compound exhibiting a
different crystal habit and spectroscopic features was isolated in the proc
ess of crystallization. Tc-99m complexes of both the diastereomers were sta
ndardized and used in animal biodistribution studies.